Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator

Homepage: carb-x.org

Parent institution: Boston University

ROR: 0381dsh28

OpenAlex ID: I4405280656

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

2017 · Evelina Tacconelli, Elena Carrara, et al. · The Lancet Infectious Diseases · 6,480

The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance

2025 · Hatim Sati, Elena Carrara, et al. · The Lancet Infectious Diseases · 1,134

Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses

2024 · Daniela Melchiorri, Tamarie Rocke, et al. · The Lancet Microbe · 93

Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps

2024 · Valeria Gigante, Richard A. Alm, et al. · Antimicrobial Agents and Chemotherapy · 39

The time to address the antibiotic pipeline and access crisis is now

2024 · Manica Balasegaram, Kevin Outterson, et al. · The Lancet · 16

Global perspective on gaps in fungal diagnostics in low-resource settings: WHO landscape analysis and research priorities for invasive fungal diseases

2026 · Maurine Murtagh, P Lewis White, et al. · The Lancet Microbe · 10

US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary—Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea

2024 · Hiwot Hiruy, Shukal Bala, et al. · Clinical Infectious Diseases · 10

Implementing an EU pull incentive for antimicrobial innovation and access: blueprint for action

2024 · Michael Anderson, Adrian Towse, et al. · The Lancet Microbe · 9

Diagnostics for priority bacterial pathogens: global gaps and research needs for curbing antimicrobial resistance in low-resource settings

2026 · Valeria Gigante, Maurine Murtagh, et al. · The Lancet Microbe · 7

Current infection control practices for multidrug-resistant organisms (MDRO): a survey of the Society for Healthcare Epidemiology of America (SHEA) research network and affiliated US-based hospitals

2026 · K.C. Coffey, Trudy Grossman, et al. · Infection Control and Hospital Epidemiology · 3

Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae : Aligning Diagnostics, Regulation, Guidelines, and Reimbursement

2026 · Betsy Wonderly Trainor, Jennifer L Osborn, et al. · Clinical Infectious Diseases · 1

Mapping the resistance landscape: A large-scale study of polymyxin-resistant pathogens circulating in low-and middle-income countries

2026 · Tania Da Silva Duarte, Holly E. E. Floyd, et al. · Research Square

639. Playing Keep Away—The Practice of Contact Precautions for Multidrug-Resistant Organisms (MDRO): A Survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network and Affiliated US-based Hospitals

2026 · K C Coffey, Trudy Grossman, et al. · Open Forum Infectious Diseases

Works count: 13

Citation count: 7,804